Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HVIPD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
aHer2- (AL6-LP1)n
|
|||||
| Synonyms |
aHer2- (AL6-LP1)n
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.6
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
US20240269308A1 aHer2- (AL6-LP1)n Linker
|
Linker Info | ||||
| Combination Type |
LP1
|
|||||